ETF.com Insight
Allogene Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 57 U.S.-traded ETFs. ALLO has around 15.6M shares in the U.S. ETF market. The largest ETF holder of ALLO is the SPDR S&P Biotech ETF (XBI), with approximately 6.47M shares. Investors may also find of interest that the ETF with the largest allocation to ALLO stock is Kelly CRISPR & Gene Editing Technology ETF (XDNA), with a portfolio weight of 4.19%. On average, U.S. ETFs allocate 0.26% of ALLO to their portfolios.
Additionally, ALLO is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALLO as a holding is the Dimensional US Sustainability Core 1 ETF (DFSU), with a return of --.